Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses on ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

The identification of promising lead compounds from high-throughput screens is still a very complex problem. A new high-throughput assay for identifying aggregation-based false positives could help.

Germany-based automotive solutions manufacturing conglomerate Continental AG is selling the Original Equipment Solutions (OESL) arm of ContiTech to U.S. private equity firm Regent. Terms of the ...

Automotive solutions provider Continental announced its intention to separate from its ContiTech business, with a sale being the most likely option. On April 8, Continental said that it is evaluating ...